Latest filing published 27 Jan 2026 for Protara Therapeutics, Inc., €49k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jesse Shefferman appears in our data through filings on Protara Therapeutics, Inc. shares, published by SEC (Form 4). We count 28 filings; the first trade dates from 9 January 2020 and the latest from 26 January 2026.
Purchases make up the whole of the open-market record (1 purchase, €34k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 18 share grants.
The newest entry dates from 27 January 2026: a share grant of €49k, in Protara Therapeutics, Inc. The last purchase on record was published on 15 August 2022, which is 1,531 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations